IMAX (IMAX)
(Delayed Data from NYSE)
$20.12 USD
-0.17 (-0.84%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $20.15 +0.03 (0.15%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth A Momentum C VGM
Income Statements
Fiscal Year end for IMAX Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 375 | 301 | 255 | 137 | 396 |
Cost Of Goods | 161 | 144 | 120 | 115 | 181 |
Gross Profit | 214 | 156 | 134 | 22 | 214 |
Selling & Adminstrative & Depr. & Amort Expenses | 164 | 161 | 123 | 143 | 137 |
Income After Depreciation & Amortization | 50 | -5 | 11 | -122 | 77 |
Non-Operating Income | 3 | 1 | 7 | 0 | 1 |
Interest Expense | 7 | 6 | 7 | 7 | 3 |
Pretax Income | 46 | -10 | 11 | -129 | 75 |
Income Taxes | 13 | 10 | 21 | 27 | 17 |
Minority Interest | 8 | 3 | 13 | -14 | 12 |
Investment Gains/Losses | 0 | 0 | 0 | -2 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 33 | -20 | -10 | -157 | 59 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 25 | -23 | -22 | -144 | 47 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 113 | 55 | 70 | -68 | 141 |
Depreciation & Amortization (Cash Flow) | 62 | 60 | 59 | 54 | 63 |
Income After Depreciation & Amortization | 50 | -5 | 11 | -122 | 77 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 55.15 | 56.67 | 59.13 | 59.24 | 61.49 |
Diluted EPS Before Non-Recurring Items | 0.61 | -0.39 | -0.48 | -2.23 | 0.76 |
Diluted Net EPS (GAAP) | 0.46 | -0.40 | -0.38 | -2.43 | 0.76 |
Fiscal Year end for IMAX Corporation falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 88.96 | 79.12 | 86.02 | 103.90 | 97.98 |
Cost Of Goods | 45.03 | 32.23 | 42.33 | 41.18 | 40.09 |
Gross Profit | 43.93 | 46.89 | 43.69 | 62.72 | 57.89 |
SG&A, R&D, and Dept/Amort Expenses | 41.05 | 34.82 | 40.95 | 40.69 | 43.66 |
Income After SG&A, R&D, and Dept/Amort Expenses | 2.88 | 12.07 | 2.74 | 22.03 | 14.23 |
Non-Operating Income | 0.49 | 0.46 | 0.50 | 1.03 | 0.64 |
Interest Expense | 2.28 | 1.95 | 1.78 | 1.48 | 1.80 |
Pretax Income | 1.08 | 10.58 | 1.46 | 21.57 | 13.07 |
Income Taxes | -4.00 | 5.16 | -1.85 | 6.56 | 3.46 |
Minority Interest | 1.49 | 2.15 | 0.77 | 3.03 | 1.26 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 5.07 | 5.42 | 3.31 | 15.02 | 9.61 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 3.58 | 3.27 | 2.54 | 11.99 | 8.35 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 53.43 | 53.41 | 54.98 | 55.54 | 55.32 |
Diluted EPS Before Non-Recurring Items | 0.07 | 0.08 | 0.08 | 0.27 | 0.17 |
Diluted Net EPS (GAAP) | 0.07 | 0.06 | 0.05 | 0.22 | 0.15 |